Examples of using Embolic in English and their translations into Polish
{-}
-
Colloquial
-
Medicine
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Venous embolic and thrombotic events.
It can be atherothrombotic or embolic.
Arterial embolic and thrombotic events.
And if it is a bus,is it a thrombotic bus or an embolic bus?
Venous embolic and thrombotic eventsc, d, i.
She has a history of A-fib and had an embolic CVA two years ago.
Arterial embolic and thrombotic eventsc, d, j.
However, there can be a delay before an embolic stroke shows up on the scan.
I have an embolic stroke that's converted to a bleed.
Axitinib has not been studied in patients who had a venous embolic or thrombotic event within the previous 6 months.
Venous embolic and thrombotic events see section 4.4.
Axitinib has not been studied in patients who had an arterial embolic or thrombotic event within the previous 12 months.
Grade 3 venous embolic and thrombotic events were reported in 0.9% of patients.
Spinal anaesthesia and multiple intramuscular injections may further increase the risk of(thrombo) embolic events at and shortly after administration of Glybera.
Grade 3 arterial embolic and thrombotic events were reported in 1.2% of patients.
In pooled clinical studies with axitinib(N 672) for the treatment of patients with RCC,venous embolic and thrombotic events were reported in 2.8% of patients receiving axitinib.
It is. before an embolic stroke shows up on the scan. However, there can be a delay.
These valves provide excellent flow characteristics but require life-long anticoagulation with blood thinners such as warfarin(Coumadin),to prevent embolic complications.
She has a history of embolic CVAs and now she's altered.
Embolic and thrombotic events including the increased risk of vessel occlusion in patients at risk of thrombosis.
The most frequent arterial embolic and thrombotic event was transient ischemic attack 0.8.
In the same study at 5 years, there was no increase in the risk of stroke including hemorrhagic,ischemic, embolic stroke, stroke type unspecified and transient ischemic attacks in FABLYN-treated patients.
Fatal arterial embolic and thrombotic events were reported in 0.3% patients receiving axitinib.
In the later stage of fibrocartilaginous embolic myelopathy, swelling may be present at the site of the blockage.
Arterial embolic and thrombotic events In clinical studies with axitinib, arterial embolic and thrombotic events(including transient ischemic attack, myocardial infarction, cerebrovascular accident and retinal artery occlusion) were reported see section 4.8.
In a controlled clinical study with axitinib for the treatment of patients with RCC,arterial embolic and thrombotic adverse reactions were reported in 4.7% of patients receiving axitinib, including myocardial infarction(1.4%), transient ischemic attack(0.8%) and cerebrovascular accident 0.6.
Grade 3/4 venous embolic and thrombotic adverse reactions were reported in 3.1% of patients receiving axitinib.
In a controlled clinical study with axitinib for the treatment of patients with RCC,venous embolic and thrombotic adverse reactions were reported in 3.9% of patients receiving axitinib, including pulmonary embolism(2.2%), retinal vein occlusion/thrombosis(0.6%) and deep vein thrombosis 0.6.
Grade 3/4 arterial embolic and thrombotic adverse reactions were reported in 3.3% of patients receiving axitinib.
In clinical studies with axitinib, venous embolic and thrombotic events(including pulmonary embolism, deep vein thrombosis, and retinal vein occlusion/thrombosis) were reported see section 4.8.

